Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
OIL
5751
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes Linked to Goldman Sachs Crude Oil Total Return In
OIL
| $47K | ﹤0.01% |
3,890
-41,480
| -91% | -$499K |
2015 Q1
1 quarter
|
|
5752
Casella Waste Systems
CWST
$5.21B
| $46K | ﹤0.01% |
8,158
-10,842
| -57% | -$60.7K |
2013 Q2
8 quarters
|
|
5753
First Trust Dividend Strength ETF
FTDS
$38.4M
| $46K | ﹤0.01% |
+1,759
| New | +$47.1K |
2015 Q2
0 quarters
|
|
5754
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$820M
| $46K | ﹤0.01% |
5,635
+46
| +0.8% | +$400 |
2013 Q4
6 quarters
|
|
5755
VolitionRx Ltd
VNRX
$5.38M
| $46K | ﹤0.01% |
575
+50
| +10% | +$3.78K |
2015 Q1
1 quarter
|
|
|
DYSL
5756
DELISTED
Dynasil Corporation of America
DYSL
| $46K | ﹤0.01% |
29,475
+402
| +1% | +$575 |
2014 Q1
5 quarters
|
|
|
WMAR
5757
DELISTED
West Marine Inc
WMAR
| $46K | ﹤0.01% |
4,757
-2,229
| -32% | -$22.1K |
2013 Q4
6 quarters
|
|
|
IPK
5758
DELISTED
SPDR S&P International Technology Sector
IPK
| $46K | ﹤0.01% |
1,388
-42
| -3% | -$1.44K |
2013 Q2
8 quarters
|
|
|
CLBH
5759
DELISTED
Carolina Bank Holdings Inc
CLBH
| $46K | ﹤0.01% |
3,815
+309
| +9% | +$3.46K |
2013 Q4
6 quarters
|
|
|
HKTV
5760
DELISTED
HONG KONG TELEVISION NETWORK LTD
HKTV
| $46K | ﹤0.01% |
8,056
-274
| -3% | -$2.01K |
2013 Q4
6 quarters
|
|
|
MTSL
5761
DELISTED
MER TELEMANAGEMENT SOLUTNS LTD
MTSL
| $46K | ﹤0.01% |
16,909
+15,901
| +1,577% | +$43.3K |
2014 Q1
5 quarters
|
|
5762
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$7.14B
| $45K | ﹤0.01% |
1,478
-2,802
| -65% | -$84.7K |
2014 Q2
4 quarters
|
|
|
AVH
5763
DELISTED
AVIANCA HOLDINGS S.A.
AVH
| $45K | ﹤0.01% |
4,393
-378,792
| -99% | -$4.27M |
2013 Q4
6 quarters
|
|
|
EGPT
5764
DELISTED
VanEck Egypt Index ETF
EGPT
| $45K | ﹤0.01% |
928
-21
| -2% | -$1.1K |
2013 Q4
6 quarters
|
|
|
VRML
5765
DELISTED
Vermillion, Inc.
VRML
| $45K | ﹤0.01% |
22,030
+2,718
| +14% | +$5.37K |
2013 Q4
6 quarters
|
|
|
CCXE
5766
DELISTED
WISDOMTREE COMMODITY COUNTRY EQUITY FND (DE)
CCXE
| $45K | ﹤0.01% |
1,880
-366
| -16% | -$9.5K |
2013 Q2
8 quarters
|
|
|
AMCC
5767
DELISTED
Applied Micro Circuits Corporation New
AMCC
| $45K | ﹤0.01% |
6,726
+1,922
| +40% | +$11.7K |
2013 Q2
8 quarters
|
|
5768
DELISTED
Carisma Therapeutics
CARM
| $44K | ﹤0.01% |
786
+613
| +354% | +$86.5K |
2014 Q1
5 quarters
|
|
5769
ALPS Medical Breakthroughs ETF
SBIO
$178M
| $44K | ﹤0.01% |
1,216
+215
| +21% | +$7.02K |
2015 Q1
1 quarter
|
|
5770
STRATTEC Security
STRT
$243M
| $44K | ﹤0.01% |
640
-233
| -27% | -$17K |
2013 Q4
6 quarters
|
|
5771
Weyco Group
WEYS
$501M
| $44K | ﹤0.01% |
1,463
-2,108
| -59% | -$61.2K |
2013 Q4
6 quarters
|
|
|
TROVW
5772
DELISTED
TrovaGene, Inc. Warrant
TROVW
| $44K | ﹤0.01% |
+5,840
| New | +$37.3K |
2015 Q2
0 quarters
|
|
5773
DELISTED
Empire Resorts, Inc.
NYNY
| $44K | ﹤0.01% |
1,729
-3,472
| -67% | -$89.7K |
2013 Q4
6 quarters
|
|
5774
DELISTED
ISHARES IBONDS MAR 2016 CORPORATE EX-FINANCIALS ETF
IBCB
| $44K | ﹤0.01% |
451
-518
| -53% | -$51.5K |
2013 Q4
6 quarters
|
|
5775
ADMA Biologics
ADMA
$2.32B
| $43K | ﹤0.01% |
4,628
+3,463
| +297% | +$29.9K |
2014 Q4
2 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.